Drug development risk and the cost of capital

Aris I. Baras; Alex S. Baras; Kevin A. Schulman

doi:10.1038/nrd3722

Drug development risk and the cost of capital

Aris I. Baras, Alex S. Baras, Kevin A. Schulman

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	347-348
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	11
Issue number	5
DOIs	https://doi.org/10.1038/nrd3722
State	Published - May 2012

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd3722

Cite this

@article{b0b7571383a94d588c4b6e0d767a13b6,

title = "Drug development risk and the cost of capital",

author = "Baras, {Aris I.} and Baras, {Alex S.} and Schulman, {Kevin A.}",

year = "2012",

month = may,

doi = "10.1038/nrd3722",

language = "English (US)",

volume = "11",

pages = "347--348",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Drug development risk and the cost of capital

AU - Baras, Aris I.

AU - Baras, Alex S.

AU - Schulman, Kevin A.

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84860353238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860353238&partnerID=8YFLogxK

U2 - 10.1038/nrd3722

DO - 10.1038/nrd3722

M3 - Short survey

C2 - 22498751

AN - SCOPUS:84860353238

SN - 1474-1776

VL - 11

SP - 347

EP - 348

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 5

ER -

Drug development risk and the cost of capital

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this